Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease
Abstract Evidence suggests neuropathic pain (NP) develops over time in sickle cell disease (SCD), contributing to a complex, difficult‐to‐treat phenotype, with management based on scant evidence. One characteristic of NP found is hyperalgesia caused by nervous system sensitization, but risk factors...
Main Authors: | Alexander K. Glaros, Michael U. Callaghan, Wally R. Smith, Ahmar U. Zaidi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.528 |
Similar Items
-
Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
by: Eulalie Laude-Pagniez, MD, et al.
Published: (2022-12-01) -
In Vitro Cytotoxic Protective Effect of Alginate-Encapsulated Capsaicin Might Improve Skin Side Effects Associated with the Topical Application of Capsaicin
by: Ariana Hudita, et al.
Published: (2021-03-01) -
Neuropathic pain: Mechanisms and therapeutic strategies
by: Georg A. Petroianu, et al.
Published: (2023-01-01) -
Postoperative pain: What can we do?
by: Mariana de Brito Gregório, et al.
Published: (2024-01-01) -
Changes in TRPV1-Mediated Physiological Function in Rats Systemically Treated With Capsaicin on the Neonate
by: Keun-Yeong Jeong
Published: (2020-04-01)